» Articles » PMID: 29673554

Subclinical Hypothyroidism and Metabolic Risk Factors Association: A Health Examination-based Study in Northern Taiwan

Overview
Journal Biomed J
Publisher Elsevier
Specialty General Medicine
Date 2018 Apr 21
PMID 29673554
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Subclinical hypothyroidism (SCH) is defined as elevation in serum thyroid-stimulating hormone (TSH) levels despite normal serum levels of free thyroxine. It remains controversial whether people with SCH have higher total cholesterol and low-density lipoprotein cholesterol levels compared to normal-thyroid subjects. The aim of this study was to assess the metabolic risk factors for SCH.

Methods: Subjects were recruited from the health examination center of Chang Gung Memorial Hospital, Linkou, from January 1, 2010 to December 31, 2011. This was a cross-sectional review of medical records. The subjects were ethnic Taiwanese residents without known thyroid disease at baseline.

Results: A total of 22,324 subjects received annual health examination at Chang Gung Memorial Hospital from 2010 to 2011. Among them, 15,943 subjects were included as the normal thyroid group (NG), and 203 subjects (101 men and 102 women) met the criteria for SCH. The prevalence of metabolic syndrome (MetS) in the NG was 26.2% in men and 18.7% in women, whereas that in the SCH group was 39.6% in men and 29.4% in women. Women in the SCH group showed significantly higher cholesterol, triglyceride, non-high density lipoprotein (HDL) and cholesterol/HDL levels than those in the NG (p < 0.05).

Conclusion: Because SCH is more prevalent in women and the risk increases with age, greater attention to the risk of MetS development is warranted. As for men, regardless of thyroid function, the risk of MetS development with age still warrants attention. Thus, our data suggest that national guidelines for screening for thyroid disease using serum TSH levels in the elderly are mandatory.

Citing Articles

Prevalence of abnormal thyroid function test in adults attending primary care setting in the year 2022 in the Kingdom of Bahrain.

Bahram S, Alhayki B, Matar H, Alkhawaja N, Rabia N, Mahfoodh Z J Family Med Prim Care. 2024; 13(10):4284-4292.

PMID: 39629419 PMC: 11610823. DOI: 10.4103/jfmpc.jfmpc_371_24.


Deciphering thyroid function and CIMT: a Mendelian randomization study of the U-shaped influence mediated by apolipoproteins.

Zhang M, Zhao C, Xing X, Lv J Front Endocrinol (Lausanne). 2024; 15:1345267.

PMID: 38586463 PMC: 10995244. DOI: 10.3389/fendo.2024.1345267.


The Correlation Between Thyroid Parameters and the Ratios of Neutrophil/Lymphocyte and Platelet/Lymphocyte in Euthyroid Type 2 Diabetic Patients.

Chen H, Ju J, Qian X, Zhu Z, Zhao C, Liu Z Diabetes Metab Syndr Obes. 2023; 16:3763-3771.

PMID: 38028987 PMC: 10679513. DOI: 10.2147/DMSO.S431941.


Association of subclinical hypothyroidism with metabolic syndrome components in a group of apparently healthy Syrians: a retrospective cross-sectional study.

Alourfi Z, Hijazi N, Alsultan M Ann Med Surg (Lond). 2023; 85(4):670-675.

PMID: 37113956 PMC: 10129081. DOI: 10.1097/MS9.0000000000000184.


Association of subclinical hypothyroidism with metabolic syndrome and its components among outpatients with first-episode drug-naïve major depressive disorder: a large-scale cross-sectional study.

Peng P, Wang Q, Zhou Y, Hao Y, Chen S, Wu Q Eur Arch Psychiatry Clin Neurosci. 2023; 274(3):573-582.

PMID: 36961565 DOI: 10.1007/s00406-023-01588-9.


References
1.
Walsh J, Bremner A, Bulsara M, OLeary P, Leedman P, Feddema P . Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005; 165(21):2467-72. DOI: 10.1001/archinte.165.21.2467. View

2.
Garduno-Garcia J, Alvirde-Garcia U, Lopez-Carrasco G, Padilla Mendoza M, Mehta R, Arellano-Campos O . TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010; 163(2):273-8. DOI: 10.1530/EJE-10-0312. View

3.
Erdogan M, Canataroglu A, Ganidagli S, Kulaksizoglu M . Metabolic syndrome prevalence in subclinic and overt hypothyroid patients and the relation among metabolic syndrome parameters. J Endocrinol Invest. 2010; 34(7):488-92. DOI: 10.3275/7202. View

4.
Duntas L, Wartofsky L . Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence?. Thyroid. 2007; 17(11):1075-84. DOI: 10.1089/thy.2007.0116. View

5.
Walsh J, Bremner A, Bulsara M, OLeary P, Leedman P, Feddema P . Subclinical thyroid dysfunction and blood pressure: a community-based study. Clin Endocrinol (Oxf). 2006; 65(4):486-91. DOI: 10.1111/j.1365-2265.2006.02619.x. View